## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-26T09:51:41.156Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Blood Sugar Diary for Diabetes"
developer_entity: "MedM Inc"
bundle_id: "com.medm.bg.app"
app_store_id: "1068204797"
google_play_id: "com.medm.medmbg.diary"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-03-30"
report_date: "2026-05-26"
last_verified: "2026-05-26"
report_version: "3.10.6"
total_reviews: 2870
overall_rating: 4.51
sentiment: "Excited"
sentiment_score: 75
confidence: "high"
confidence_score: 0.8
top_praise_theme: "Manual data entry and clear visual trending tools support effective diabetes management for users"
top_complaint_theme: "Bluetooth connectivity failures with specific glucose monitors prevent automated data synchronization"
top_request_theme: "Integrated A1C calculator on the home screen would improve daily health insight accessibility"
review_sample_size: 60
total_review_count: 60
analyzed_review_count: 60
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 3
nemesis: "mySugr - Diabetes Tracker Log"
competitor_count: 8
tags: ["medical", "freemium", "excited sentiment", "mobile app", "app review", "app analysis", "individuals", "managing", "gestational"]
canonical_url: "https://marlvel.ai/intel-report/medical/blood-sugar-diary-for-diabetes"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Blood Sugar Diary for Diabetes App Audit

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Rating 4.51 · Sentiment Excited
- **Recent focus**: Bluetooth connectivity failures with specific glucose monitors prevent automated data synchronization (top complaint) · Manual data entry and clear visual trending tools support effective diabetes management for users (top praise) · Integrated A1C calculator on the home screen would improve daily health insight accessibility (top request)

> **TL;DR:** Blood Sugar Diary for Diabetes is a medical app by MedM Inc, rated 4.51/5 by 2.9K users, with Excited user sentiment (75/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Blood Sugar Diary for Diabetes maintains Excited user sentiment (4.51/5 from 2.9K reviews), with users consistently praising manual data entry and clear visual trending tools support effective diabetes management for users.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.51/5 (2.9K reviews) |
| **User Mood** | Excited |
| **Category** | Medical |
| **Developer** | MedM Inc |
| **Pricing** | Freemium |
| **Platforms** | iOS & Android |
| **Confidence** | High (0.8/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** MedM Inc
- **Category:** Medical
- **Target Audience:** Individuals managing Type 1, Type 2, or Gestational diabetes who require automated data collection from medical devices.
- **Platforms:** iOS & Android
- **Version Audited:** 3.10.6
- **Audit Date:** 2026-05-26
- **Signal Count:** 60 reviews analyzed
- **Confidence:** High (0.8/1.0)
- **App Store ID (iOS):** 1068204797
- **Bundle ID:** com.medm.bg.app
- **Google Play ID:** com.medm.medmbg.diary
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-05-26
- **Short Description:** Diabetes diary for tracking Blood Glucose, A1C, Ketone, Blood Pressure & Weight

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Blood Sugar Diary for Diabetes is a medical tracking app for iOS and Android that aggregates data from over 50 glucose meters and health sensors.
**Why users hire it:** Users hire the app to centralize fragmented health data into a single, physician-ready report, reducing the manual burden of chronic condition management.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Bluetooth Device Connectivity:** Automatic data collection from over 50 brands of glucose meters and health sensors via Bluetooth
- **[Standard] Multi-Parameter Health Logging:** Manual or automatic tracking of 14 health metrics including A1C and blood pressure
  * *User Intent:* Users want visibility into their own performance and progress.
- **[Differentiator] Data Sharing and Remote Monitoring:** Allows sharing of health records with family members, caregivers, or doctors
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Medical Category — the app maintains a presence in global medical charts, holding a #69 Grossing rank in the US. The gap between its free-tier reach and grossing performance suggests the premium subscription is effectively capturing power users.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free tier with basic logging, Premium membership with data sync, sharing, and advanced notifications
- **Analysis:** Freemium model gates interoperability and remote monitoring features to drive subscription conversion.

<!-- section:sentiment -->
## 🟢 User Sentiment (High Confidence: 60 of 60 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 4.51/5
- **Platform Split:** iOS 4.5/5 (93 ratings) | Android 4.5/5 (2.8K ratings)
- **Overall Sentiment:** Excited

### Top Praises
- **Manual data entry and clear visual trending tools support effective diabetes management for users**
- **Ad-free experience and intuitive interface design encourage consistent daily health tracking habits**

### Top Complaints (Impact Areas)
- **Bluetooth connectivity failures with specific glucose monitors prevent automated data synchronization**
- **Mandatory account creation and sign-in requirements frustrate users seeking simple offline functionality**

### Top Requests (What Users Want)
- **Integrated A1C calculator on the home screen would improve daily health insight accessibility**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Hardware-agnostic connectivity layer [50+ devices]
- Ad-free interface [User reviews]
- Multi-parameter logging [14 metrics]

**Critical Frictions:**
- Mandatory account registration [User complaints]
- Bluetooth pairing instability [High-frequency complaint]
- Limited offline-first functionality [User feedback]

**Growth Levers:**
- Integrated A1C calculator [User request]
- B2B partnerships with healthcare providers [Remote monitoring feature]
- Wearable device expansion [Market trend]

**Market Threats:**
- Proprietary sensor lock-in [Abbott/LifeScan]
- Gamified rival engagement [mySugr]
- OS-level health integration [Apple/Google native features]

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app introduced mandatory account registration, causing new user friction, while overall sentiment scores improved despite persistent Bluetooth connectivity issues.

**Overall trend**: Mixed
**Compared at**: 2026-05-26

### High-impact changes
- **[Shifted] Sentiment Improvement** (sentiment) — Overall sentiment shifted from mixed to positive, with the sentiment score increasing from 58 to 75.
- **[Added] Mandatory Account Registration** (swot) — New weakness identified: mandatory account registration is now a primary user complaint and barrier to entry.

### Medium-impact changes
- **[Removed] Oxiline Pairing Specificity** (swot) — The specific complaint regarding Oxiline hardware has been generalized to broader Bluetooth connectivity failures.
- **[Removed] 7-Day Graph Limit** (swot) — The 7-day graphing limitation is no longer listed as a primary weakness in the SWOT analysis.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Blood Sugar Diary for Diabetes vs mySugr - Diabetes Tracker Log — Head to Head
- **[mySugr - Diabetes Tracker Log](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr)** by mySugr GmbH: Dominates the diabetes tracking niche with massive user scale and a high-frequency release cadence that keeps the product ahead of market standards.
  - **Moat strength:** High — sustainable advantage over 12 months
  - **Key differences:**
    - Integrates gamified logging experiences that significantly increase daily user engagement compared to standard manual entry trackers.
    - Maintains a high-velocity release cycle with 10 updates in six months, ensuring rapid adaptation to new OS features.
    - Offers a robust ecosystem of connected devices and professional reporting tools that create high switching costs for users.
  - **Where Blood Sugar Diary for Diabetes wins:**
    - ✅ Provides a more streamlined, hardware-agnostic connectivity layer for over 50 different glucose meters via Bluetooth.
    - ✅ Focuses on a multi-condition tracking approach including blood pressure and weight, offering a broader health overview.
  - **Where mySugr - Diabetes Tracker Log wins:**
    - ❌ Leverages deep gamification mechanics to turn tedious daily blood sugar logging into a more rewarding user experience.
    - ❌ Maintains a massive, established community-driven data set that powers superior trend analysis and personalized insights.
  - **Verdict:** The target app must pivot toward community-driven features or advanced gamification to compete with the high retention rates of this market leader.

### Contenders (Strong Challengers)
- **[OneTouch Reveal® app](https://marlvel.ai/intel-report/medical/com-lifescan-reveal)** by LifeScan, Inc. [Moat: High]: A major industry-backed competitor that leverages deep integration with specific hardware ecosystems to lock in users.
  - Provides seamless, automated data synchronization specifically optimized for the OneTouch hardware ecosystem.
  - Features clinical-grade reporting tools designed specifically for physician-patient data sharing during medical consultations.
- **[Glucose Buddy Diabetes Tracker](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy)** by Azumio Inc. [Moat: Medium]: A long-standing incumbent in the diabetes space with a highly refined, specialized feature set for glucose management.
  - Offers a mature, battle-tested interface that prioritizes rapid data entry for users with high-frequency testing needs.
  - Includes specialized educational content modules that help users interpret their glucose trends over long-term periods.
- **[Libre by Abbott](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us)** by Abbott Labs [Moat: High]: A powerful hardware-tethered app that dominates the continuous glucose monitoring (CGM) segment of the market.
  - Functions as the primary interface for CGM hardware, providing real-time glucose streaming that manual trackers cannot replicate.
  - Benefits from a massive, captive user base tied directly to the purchase of proprietary medical sensor hardware.

### Peers (What They Do Better)
- **[Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe)** by MediSafe Inc.: Adjacent medical utility that shares the target's focus on chronic condition management and medication adherence.
  - Specializes in complex medication scheduling and multi-family member tracking, which complements the target's glucose-centric focus.
  - Utilizes a sophisticated notification engine to ensure high adherence rates for complex multi-drug regimens.
- **[Kardia](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg)** by AliveCor, Inc.: A high-end medical monitoring app that represents the premium tier of connected health diagnostics.
  - Provides clinical-grade ECG analysis capabilities that far exceed the diagnostic scope of standard glucose tracking apps.
  - Operates on a hardware-plus-subscription model that creates a strong, defensible revenue moat.
- **[Blood Pressure Tracker SmartBP](https://marlvel.ai/intel-report/medical/com-evolvemedicalsystems-sbp)** by Evolve Medical Systems, LLC: Directly competes with the target's secondary feature set of blood pressure tracking.
  - Focuses exclusively on blood pressure analytics, offering deeper visualization and trend analysis for cardiovascular health.
  - Maintains a very high update frequency, signaling a commitment to iterative UX improvements for BP tracking.

### New Kids on the Block (What's Innovative)
- **[Finger Blood Pressure: BP Mate](https://marlvel.ai/intel-report/medical/com-galaxy-health-bp)** by 军 刘: An emerging player in the health tracking space with recent activity, though currently limited by lower user sentiment.

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v3.10.5, 2 months ago):** General performance improvements and bug fixes.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Migrated support to Google Health Connect.
- Ships regular stability and bug fixes.

> **Cadence:** 2 total versions · 0 majors in last 6 months · 56 days since last update · 6 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Blood Sugar Diary for Diabetes is a market-leading medical app that is free with in-app purchases.
With a 4.51/5 rating from 2.9K reviews, it delivers strong user satisfaction.

<!-- speakable-start -->
> **Bottom Line:** The app wins through its broad hardware-agnostic connectivity, but the shift to mandatory account registration risks alienating its core user base, so the PM should prioritize Bluetooth stability and offline-first access to defend the retention baseline.
<!-- speakable-end -->

**Best for:** Individuals managing Type 1, Type 2, or Gestational diabetes who require automated data collection from medical devices.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [HIGH IMPACT] Audit Bluetooth pairing logic because connectivity failure is the top complaint → reduce churn — *Connectivity friction is the #1 complaint theme in user reviews.* _(trade-off: deprioritize Push the A1C calculator feature to Q3 — connectivity stability has higher retention impact.)_
- [ ] [PIVOT] [MEDIUM IMPACT] Implement offline-first mode because mandatory sign-in is a top friction point → increase new-user conversion — *User sentiment data indicates account registration is a primary barrier to entry.* _(trade-off: deprioritize Pause the premium-tier marketing banner rollout — onboarding friction is a larger growth bottleneck.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Gamified logging experiences (available in mySugr but missing here)
- Educational content modules (available in Glucose Buddy but missing here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Stable

The medical tracking market is shifting toward deeper OS-level integration, and the app's ability to sync with Google Health Connect keeps it relevant. However, the current friction from mandatory sign-ins threatens to offset these technical gains, so the PM must prioritize user-facing UX to maintain the current rating baseline.

- 🔴 Mandatory account registration requirements are driving user frustration, which risks eroding the app's reputation for privacy and simplicity.
- 🟢 The app's continued investment in Google Health Connect integration ensures long-term interoperability, keeping it competitive against native OS health trackers.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.51/5 |
| Total Reviews | 2.9K |
| Sentiment | Excited (75/100) |
| Confidence | High |
| Pricing Model | Freemium |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Blood Sugar Diary for Diabetes** (this app) | 4.51/5 | Excited | MedM Inc |
| [Libre by Abbott](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us) | 4.6/5 | N/A | Abbott Labs |
| [Medisafe Medication Management](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) | 4.7/5 | Upset | MediSafe Inc. |
| [Kardia](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg) | 4.8/5 | N/A | AliveCor, Inc. |
| [OneTouch Reveal® app](https://marlvel.ai/intel-report/medical/com-lifescan-reveal) | 4.8/5 | N/A | LifeScan, Inc. |
| [Blood Pressure Tracker SmartBP](https://marlvel.ai/intel-report/medical/com-evolvemedicalsystems-sbp) | 4.6/5 | N/A | Evolve Medical Systems, LLC |

## Company Profile
- **Developer:** MedM Inc
- **Website:** [https://www.medm.com/apps/diabetes.html](https://www.medm.com/apps/diabetes.html)
- **Social:** [Instagram](https://www.instagram.com/medminc) · [Facebook](https://www.facebook.com/MedM-1453551091545209) · [X/Twitter](https://twitter.com/medminc) · [YouTube](https://www.youtube.com/channel/UCwsHMAkXSSYkfGeDeQ9KXZQ) · [LinkedIn](https://www.linkedin.com/company/medminc)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/blood-sugar-diary-for-diabetes/id1068204797?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.medm.medmbg.diary)
- **Dev Site:** [Official Website](https://www.medm.com/apps/diabetes.html)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*Libre by Abbott*](https://marlvel.ai/intel-report/medical/com-abbott-adc-freestyle-libre-us) (Abbott Labs) — 4.6/5 Rating | N/A Sentiment
- [*Medisafe Medication Management*](https://marlvel.ai/intel-report/medical/com-medisafe-medisafe) (MediSafe Inc.) — 4.7/5 Rating | Terrible Sentiment
- [*Kardia*](https://marlvel.ai/intel-report/medical/com-alivecor-professional-aliveecg) (AliveCor, Inc.) — 4.8/5 Rating | N/A Sentiment
- [*OneTouch Reveal® app*](https://marlvel.ai/intel-report/medical/com-lifescan-reveal) (LifeScan, Inc.) — 4.8/5 Rating | N/A Sentiment
- [*Blood Pressure Tracker SmartBP*](https://marlvel.ai/intel-report/medical/com-evolvemedicalsystems-sbp) (Evolve Medical Systems, LLC) — 4.6/5 Rating | N/A Sentiment
- [*Finger Blood Pressure: BP Mate*](https://marlvel.ai/intel-report/medical/com-galaxy-health-bp) (军 刘) — 4.5/5 Rating | N/A Sentiment
- [*Glucose Buddy Diabetes Tracker*](https://marlvel.ai/intel-report/medical/com-oneapponecause-glucosebuddy) (Azumio Inc.) — 4.8/5 Rating | Terrible Sentiment
- [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/intel-report/medical/com-mysugr-companion-mysugr) (mySugr GmbH) — 4.7/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.8/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 60
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/blood-sugar-diary-for-diabetes)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.